Skip to the page

Data / Form D filings / Araceli Biosciences Inc.

Araceli Biosciences Inc.: Form D filings

Araceli Biosciences Inc., a technology company in Tigard, OR, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on December 9, 2025, reports $12.2 million sold of a $14.1 million offering to 28 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7405 SW TECH CENTER DRIVE, SUITE A160, Tigard, OR, 97223
Phone
(503) 853-4144
Industry
Other Technology
Entity type
Corporation
Incorporated in
Oregon
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1975014

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 9, 2025Amendment$14,061,994$12,236,994$1,825,00028Dec 31, 2024sec.gov
Jan 15, 2025New notice$8,000,351$2,525,000$5,475,3516Dec 31, 2024sec.gov
Apr 26, 2023New notice$4,000,000$2,225,000$1,775,0003Apr 11, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Matt BeaudetExecutive Officer, Director
Kirk MalloyDirector
Sean O'NeillDirector
Shawn MacDonaldExecutive Officer
Samraat RahaDirector
Kevin GabeleinDirector
J. William FreytagDirector
William CortelyouDirector
Bruce RhineDirector

Other technology companies in Oregon that filed recently

Every Form D from the week of Dec 8, 2025 · All recent filings in Oregon · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Araceli Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.